|
Sorokina L.N., Pavlova A.S., Mineev V.N., Trofimov V.I.
Chronic obstructive pulmonary disease in combination with type 2 diabetes mellitus: features of the clinical picture
|
№8 / 2021
|
|
Baranov D.Z., Trofimov V.I., Lapin S.V., Mazing A.V., Kholopova I.V., Kuznetsova D.A., Moshnikova A.N., Blinova T.V.
Evaluation of periostin in case of bronchoostructive diseases
|
№8 / 2021
|
|
Ladnov D.V., Kulik V.V., Kirpichnikov S.I., Shaporova N.L.
Mild forms of COVID-19: the clinical course features in patients with chronic obstructive pulmonary disease
|
№8 / 2021
|
|
Naumov A.V., Prokofieva T.V., Polunina O.S., Saroyants L.V., Lipnitskaya E.A., Polunina E.A.
Levels of apoptosis indicators in patients with myocardial infarction on the background of chronic obstructive pulmonary disease depending on the time of development of myocardial ischemia
|
№6 / 2021
|
|
Babak S.L., Gorbunova M.V., Malyavin A.G.
Strategy of mucolytic therapy: ambroxol
|
№1 / 2021
|
|
Korneeva N.V., Khelimskaya I.V., Kim Ch.O., An A.S., Schennikov E.L., Belun I.F., Praslova N.Yu.
Analysis of smoking behavior in patients with chronic obstructive pulmonary disease
|
№5 / 2020
|
|
Varvarina G.N., Makarova E.V., Plastinina S.S., Milyutina M.Y., Menkov N.V., Saltsev S.G.
Obstructive pulmonary diseases and disorders of carbohydrate metabolism: hospital patients hypoglycemia is focused on
|
№6 / 2019
|
|
Bakulin I.G., Abatsieva M. P., Skalinskaya M.I., Zhuravleva M.S.
Clinical and medico-social significance of NAFLD through the prism of comorbidity
|
№6 / 2019
|
|
Mayorova M.V., Grigorieva N.Yu., Samolyuk M.O.
The role of endothelial dysfunction and oxidative stress in the formation of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease
|
№5 / 2019
|
|
Karoli N.A., Borodkin A.V., Rebrov A.P.
Peculiarities of chronic heart failure in COPD patients
|
№5 / 2019
|
|
Malyavin A.G., Avksentieva M.V., Babak S.L., Dzanaeva A.V.
Medical and economical consequences of extension of medicamentally support program for patients with COPD in Russia
|
№5 / 2019
|
|
Adasheva T.V., Bolieva L.Z., Lee V.V., Malyavin A.G.
Use of beta-blockers in COPD: mythical risk or justified benefit?
|
№5 / 2019
|
Русский
